• K Yonezawa, O Horie, A Yoshioka, S Matsuki, T Tenjin, Y Tsukamura, M Yoneda, K Shibata, Y Koike, T Nomura, M Yokoyama, N Urahama, and Mitsuhiro Ito.
• Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan.
• Int J Lab Hematol. 2010 Dec 1; 32 (6 Pt 2): 598-605.

AbstractThe mean myeloperoxidase index (MPXI) is calculated during the routine complete blood count performed using the autoanalyzer ADVIA120/2120. The pattern of changes in the neutrophil myeloperoxidase levels in patients with specific infectious diseases was analyzed by assessing the MPXI levels. In patients with bacterial sepsis, identified by positive blood-culture tests, with (n = 29) and without (n = 51) systemic inflammatory response syndrome, the mean MPXI significantly reduced to -3.18 and -2.06, respectively. In contrast, among patients with nontuberculous nonseptic bacterial infections (n = 40), the mean MPXI significantly elevated to 5.51, while tuberculosis patients (n = 37) and patients with viral infection (n = 60) showed an unchanged MPXI (mean values, -0.46 and -1.06, respectively). Among the parameters of inflammation, only the C-reactive protein values showed a weak correlation with the MPXI levels. [Conclusion] These results indicate that MPXI is correlated with some specific infectious states, i.e. MPXI is low in bacterial sepsis and high in nontuberculous nonseptic bacterial infections. MPXI appears to be an independent and useful biomarker for the diagnosis and follow-up of infectious diseases, especially when the MPXI values are obtained at regular intervals during the disease courses of the patients.© 2010 Blackwell Publishing Ltd.

29 keywords...

hide…